Outcome of the Board Meeting held on Tuesday, July 14, 2026 and the disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding the approval of the Scheme of Amalgamation of Achyut Healthcare Limited with and into Zenith Healthcare Limited and their respective shareholders and creditors under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013. After considering the recommendation of the Audit Committee and the Committee of Independent Director of the Company, has inter-alia considered and approved a Scheme of Amalgamation of Achyut Healthcare Limited (Transferor Company) with and into Zenith Healthcare Limited (Transferee Company) and their respective shareholders and creditors (Scheme) under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 (Act), rules and regulation made thereunder read with Section 2(6) of the Income Tax, 2025, for the aforementioned amalgamation, consequent dissolution of the Transferor Company without winding up and the issuance of equity shares by the Transferee Company to the equity shareholders of the Transferor Company as consideration. After considering the recommendation of the Audit Committee and the Committee of Independent Directors of the Company, has inter-alia considered and approved a Scheme of Amalgamation of Achyut Healthcare Limited (Transferor Company) with and into Zenith Healthcare Limited (Transferee Company) and their respective shareholders and creditors (Scheme), under Section 230 to 232 and other applicable provisions of the Companies Act, 2013 (Act), rules and regulations made thereunder read with Sections 2(6) of the Tax Act, 2025, for the aforementioned amalgamation, consequent dissolution of the Transferor Company without winding up and the issuance of equity shares by the Transferee Company to the equity shareholders of the Transferor Company as consideration. (As Per BSE Announcement Dated on 14.07.2026)

Outcome of the Board Meeting held on Tuesday, July 14, 2026 and the disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding the approval of the Scheme of Amalgamation of Achyut Healthcare Limited with and into Zenith Healthcare Limited and their respective shareholders and creditors under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 After considering the recommendation of the Audit Committee and the Committee of Independent Director of the Company, has inter-alia considered and approved a Scheme of Amalgamation of Achyut Healthcare Limited (Transferor Company) with and into Zenith Healthcare Limited (Transferee Company) and their respective shareholders and creditors (Scheme) under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 (Act), rules and regulation made thereunder read with Section 2(6) of the Income Tax, 2025, for the aforementioned amalgamation, consequent dissolution of the Transferor Company without winding up and the issuance of equity shares by the Transferee Company to the equity shareholders of the Transferor Company as consideration. After considering the recommendation of the Audit Committee and the Committee of Independent Directors of the Company, has inter-alia considered and approved a Scheme of Amalgamation of Achyut Healthcare Limited (Transferor Company) with and into Zenith Healthcare Limited (Transferee Company) and their respective shareholders and creditors (Scheme), under Section 230 to 232 and other applicable provisions of the Companies Act, 2013 (Act), rules and regulations made thereunder read with Sections 2(6) of the Tax Act, 2025, for the aforementioned amalgamation, consequent dissolution of the Transferor Company without winding up and the issuance of equity shares by the Transferee Company to the equity shareholders of the Transferor Company as consideration.

Intimation of approval by Board of Directors for Scheme of Amalgamation between Wholly-owned-subsidiaries

Approved the proposal to enter into a Business Transfer Agreement (BTA) with Virinchi Health Care Private Limited (VHCPL), a subsidiary of Virinchi Limited (Company), for the acquisition of the Primary and Secondary Healthcare Business Division operated under the 'Bristlecone Hospitals' brand, together with all related assets, liabilities, contracts, employees and other rights and obligations forming part of the said business division, as a going concern on a slump-sale basis, subject to the approval of the shareholders of the Company and receipt of such other regulatory, statutory or other approvals, consents and permissions as may be required, with the transaction being effective from April 1, 2026.

In reference to captioned subject, it is hereby informed that Kalpataru Properties (Thane) Limited (“the Transferee Company” or KPTL”), a wholly owned subsidiary and Kalpataru Hills Residency Private Limited (“the Transferor Company” or “KHRPL”), a step-down subsidiary of the Company, in their respective meetings of the Board of Directors held today i.e. 8th July, 2026, have considered and approved the Scheme of Amalgamation between KHRPL and KPTL and their respective shareholders under section 233 and other applicable provisions of the Companies Act, 2013 and rules made there under (“Scheme”)